Gaurav Shah - Net Worth and Insider Trading
Gaurav Shah Net Worth
The estimated net worth of Gaurav Shah is at least $9 Million dollars as of 2025-04-27. Gaurav Shah is the CEO of Rocket Pharmaceuticals Inc and owns about 1,198,918 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $9 Million. Details can be seen in Gaurav Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gaurav Shah has not made any transactions after 2025-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gaurav Shah
Gaurav Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gaurav Shah owns 2 companies in total, including Rocket Pharmaceuticals Inc (RCKT) , and Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Gaurav Shah’s form 4 insider trades.
Insider Ownership Summary of Gaurav Shah
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | 2025-04-10 | director & See Remarks |
| TALS | Talaris Therapeutics Inc | 2021-05-06 | director |
Gaurav Shah Latest Holdings Summary
Gaurav Shah currently owns a total of 1 stock. Gaurav Shah owns 1,198,918 shares of Rocket Pharmaceuticals Inc (RCKT) as of April 10, 2025, with a value of $9 Million.
Latest Holdings of Gaurav Shah
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | 2025-04-10 | 1,198,918 | 7.23 | 8,668,177 |
Holding Weightings of Gaurav Shah
Gaurav Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Gaurav Shah has made a total of 10 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 2 buys and 8 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the acquisition of 20,000 shares on April 10, 2025, which cost Gaurav Shah around $101,600.
Insider Trading History of Gaurav Shah
- 1
Gaurav Shah Trading Performance
GuruFocus tracks the stock performance after each of Gaurav Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gaurav Shah is -45.91%. GuruFocus also compares Gaurav Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gaurav Shah within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gaurav Shah's insider trading performs compared to the benchmark.
Performance of Gaurav Shah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.17 | | | | | |
| Relative Return to S&P 500(%) | -8.86 | | | | | |
Gaurav Shah Ownership Network
Ownership Network List of Gaurav Shah
Ownership Network Relation of Gaurav Shah
Gaurav Shah Owned Company Details
What does Rocket Pharmaceuticals Inc do?
Who are the key executives at Rocket Pharmaceuticals Inc?
Gaurav Shah is the director & See Remarks of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include See Remarks John Militello , Chief Operating Officer Kinnari Patel , and Chief Medical Officer Jonathan David Schwartz .
Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary
Over the past 18 months, Gaurav Shah made 6 insider transaction in Rocket Pharmaceuticals Inc (RCKT) with a net sale of 47,106. Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 26,646 shares made by John Militello , a net sale of 14,148 shares made by Martin Wilson , and a net sale of 4,734 shares made by Kinnari Patel .
In summary, during the past 3 months, insiders sold 51,640 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 41,099 shares, with a net sale of 10,541 shares. During the past 18 months, 822,953 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 41,099 shares were bought by its insiders, resulting in a net sale of 781,854 shares.
Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rocket Pharmaceuticals Inc Insider Transactions
Gaurav Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Gaurav Shah. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gaurav Shah's mailing address is: New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
